Publication of Original Research in Urologic Journals – A Neglected Orphan?

Por Mani, Jens, Makarević, Jasmina, Juengel, Eva, Ackermann, Hanns, Nelson, Karen, Haferkamp, Axel, Blaheta, Roman A.
Publicado em 2012

Resistance after Chronic Application of the HDAC-Inhibitor Valproic Acid Is Associated with Elevated Akt Activation in Renal Cell Carcinoma In Vivo

Por Juengel, Eva, Makarević, Jasmina, Tsaur, Igor, Bartsch, Georg, Nelson, Karen, Haferkamp, Axel, Blaheta, Roman A.
Publicado em 2013

I Publish in I Edit? - Do Editorial Board Members of Urologic Journals Preferentially Publish Their Own Scientific Work?

Por Mani, Jens, Makarević, Jasmina, Juengel, Eva, Ackermann, Hanns, Nelson, Karen, Bartsch, Georg, Haferkamp, Axel, Blaheta, Roman A.
Publicado em 2013

Resistance to the mTOR Inhibitor Temsirolimus Alters Adhesion and Migration Behavior of Renal Cell Carcinoma Cells through an Integrin α5– and Integrin β3–Dependent Mechanism()()...

Por Juengel, Eva, Makarević, Jasmina, Reiter, Michael, Mani, Jens, Tsaur, Igor, Bartsch, Georg, Haferkamp, Axel, Blaheta, Roman A.
Publicado em 2014

Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib

Por Juengel, Eva, Kim, Dana, Makarević, Jasmina, Reiter, Michael, Tsaur, Igor, Bartsch, Georg, Haferkamp, Axel, Blaheta, Roman A
Publicado no J Cell Mol Med (2015)

Mycophenolate mofetil modulates adhesion receptors of the beta1 integrin family on tumor cells: impact on tumor recurrence and malignancy

Por Engl, Tobias, Makarević, Jasmina, Relja, Borna, Natsheh, Iyad, Müller, Iris, Beecken, Wolf-Dietrich, Jonas, Dietger, Blaheta, Roman A
Publicado em 2005

Amygdalin Blocks Bladder Cancer Cell Growth In Vitro by Diminishing Cyclin A and cdk2

Por Makarević, Jasmina, Rutz, Jochen, Juengel, Eva, Kaulfuss, Silke, Reiter, Michael, Tsaur, Igor, Bartsch, Georg, Haferkamp, Axel, Blaheta, Roman A.
Publicado em 2014

Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells

Por Makarević, Jasmina, Tawanaie, Nassim, Juengel, Eva, Reiter, Michael, Mani, Jens, Tsaur, Igor, Bartsch, Georg, Haferkamp, Axel, Blaheta, Roman A
Publicado em 2014

Amygdalin Influences Bladder Cancer Cell Adhesion and Invasion In Vitro

Por Makarević, Jasmina, Rutz, Jochen, Juengel, Eva, Kaulfuss, Silke, Tsaur, Igor, Nelson, Karen, Pfitzenmaier, Jesco, Haferkamp, Axel, Blaheta, Roman A.
Publicado em 2014

Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the c...

Por Wedel, Steffen, Hudak, Lukasz, Seibel, Jens-Michael, Makarević, Jasmina, Juengel, Eva, Tsaur, Igor, Waaga-Gasser, Ana, Haferkamp, Axel, Blaheta, Roman A
Publicado em 2011

Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells

Por Tsaur, Igor, Hudak, Lukasz, Makarević, Jasmina, Juengel, Eva, Mani, Jens, Borgmann, Hendrik, Gust, Kilian M, Schilling, David, Bartsch, Georg, Nelson, Karen, Haferkamp, Axel, Blaheta, Roman A
Publicado no J Cell Mol Med (2015)

CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study

Por Tsaur, Igor, Noack, Anika, Makarevic, Jasmina, Oppermann, Elsie, Waaga-Gasser, Ana Maria, Gasser, Martin, Borgmann, Hendrik, Huesch, Tanja, Gust, Kilian M., Reiter, Michael, Schilling, David, Bartsch, Georg, Haferkamp, Axel, Blaheta, Roman A.
Publicado no Cancer Res Treat (2015)